Noted: Currently the treatments for patients diagnosed with neuroendocrine cancer do not offer an encouraging long-term prognosis.
“The goals of that treatment are to help patients live longer and live better but we wouldn’t be curing patients with that cure,” said Dr. Noelle LoConte, and oncologist with the University of Wisconsin School of Medicine and Public Health.
Wolff lost her battle with cancer on April 22, 2013, but three years to the day after her passing UW Health announced a phase I clinical trial of a treatment developed at the Carbone Cancer Center.